CD8A and breast neoplasm: In contrast, in a breast tumor model, an increase in CD8+ T cell motility by CTLA-4 blockade did not promote tumor killing, whereas a combination with radiotherapy decreased CD8+ T cell motility and enhanced tumor injury [139].